Monitorings the Physiological Mechanism of Airway Pressure Release Ventilation in ARDS Patients by EIT

November 2, 2022 updated by: Wuhan Union Hospital, China

Monitorings the Physiological Mechanism of Airway Pressure Release Ventilation(APRV) in Acute Respiratory Distress Syndrome (ARDS) Patients by Electrical Impedance Tomography(EIT)

Effects of airway pressure release ventilation on pulmonary ventilation, shunt and perfusion in patients with ARDS

Study Overview

Status

Recruiting

Detailed Description

Effects of airway pressure release ventilation on respiratory mechanisms including ventilation distribution, intrapulmonary shunt and V/Q match in lungs of ARDS evaluated by EIT at different time points.

Study Type

Observational

Enrollment (Anticipated)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: xin zhao, master
  • Phone Number: 027-85351607 15927336285
  • Email: 619641364@qq.com

Study Contact Backup

  • Name: xiaojing zou, PhD
  • Phone Number: 027-85351607 13995518630
  • Email: 249126734@qq.com

Study Locations

    • Hubei
      • Wuhan, Hubei, China, 430000
        • Recruiting
        • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
        • Contact:
          • xin zhao, master
          • Phone Number: 027-85351607 15927336285
          • Email: 619641364@qq.com

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Include as many subjects as possible according to the research protocol

Description

Inclusion Criteria:

  1. 18 years old < age < 80 years old
  2. Diagnosed as moderate or severe ARDS according to the Berlin 2014 definition
  3. Predicted APRV mechanical ventilation for more than 72 hours

Exclusion Criteria:

Excluded if any of the following exclusion criteria are met:

  1. APRV contraindications such as pneumothorax, severe chronic obstructive pulmonary disease, severe asthma, intracranial hypertension
  2. Pregnant women
  3. Severe cardiac dysfunction (New York Heart Association class III or IV, acute coronary syndrome or sustained ventricular tachyarrhythmia), right heart enlargement due to chronic cardiopulmonary disease, cardiogenic shock or cardiac hand
  4. Refractory shock
  5. BMI>35

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
tidal volume distribution during APRV at 24 hours after APRV
Time Frame: 24 hours after APRV mechanical ventilation
we will use electrical impedance tomography(EIT) to monitor tidal volume distribution during APRV
24 hours after APRV mechanical ventilation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
tidal volume distribution during APRV
Time Frame: Before APRV mechanical ventilation and 2, 6, 12, 48, 72 hours after APRV mechanical ventilation
tidal volume distribution electrical impedance tomography(EIT) during APRV
Before APRV mechanical ventilation and 2, 6, 12, 48, 72 hours after APRV mechanical ventilation
Intrapulmonary shunt during APRV
Time Frame: Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
Intrapulmonary shunt percent represented regions that were only perfused calculated as the slope of regional impedance-time curves after saline bolus injection evaluated by EIT
Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
V/Q match
Time Frame: Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
V/Q match is monitored by EIT
Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
tidal volume(Vt)
Time Frame: Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
Vt is the volume of air inhaled or exhaled per breath during mechanical ventilation
Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
Plateau pressure
Time Frame: Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
Plateau pressure is the airway pressure at the end of inspiratory pause
Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
Positive end breath pressure
Time Frame: Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
Positive end breath pressure(PEEP) is the airway pressure at the end of each breath which is set by clinicians
Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
Driving pressure(DP)
Time Frame: Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
DP=Plateau pressure-PEEP
Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
Compliances(Cs)
Time Frame: Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
Cs=DP/Vt
Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
Peak pressure
Time Frame: Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
Peak pressure is the maximum pressure in the airway during ventilation occurs at the end of inspiration.
Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
Mean pressure
Time Frame: Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
Mean pressure is the average airway pressure over a number of breathing cycles
Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
Right ventricular area fractional change
Time Frame: Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
Right ventricular area fractional change is a simple and repeatable ultrasound method for evaluating right ventricular function. Methods: The right ventricular end-diastolic area (RVEDA) and right ventricular end- systolic area (RVESA) were measured on the apical four-chamber section by two-dimensional ultrasound. RVAC=(RVEDA- RVESA)/RVEDA*100%.
Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
Tricuspid annular systolic displacement (TAPSE)
Time Frame: Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
TAPSE:Measurement method: TAPSE was measured on the four-chamber section of the apex of the heart by M-mode ultrasound. the sampling line was placed at the side wall of the tricuspid valve ring, parallel to the free wall of the right ventricle as far as possible, and the displacement of the tricuspid valve ring was measured from the end of diastole to the end of systole.
Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
Tricuspid annular systolic S' velocity (TS')
Time Frame: Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
TS' is an objective and accurate ultrasound technique for evaluating right ventricular function.Measurement method:The sample volume was applied to the free wall of the RV and the peak velocity of tricuspid annulus motion was measured in the four-chamber section of the apex by tissue doppler imaging (TDI).
Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
Right ventricular end-diastolic area/left ventricular end-diastolic area (RVEDA/LVEDA)
Time Frame: Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
RVEDA/LVEDA a simple and repeatable ultrasound method for evaluating dynamics changes of right ventricular function.Methods: The right ventricular end-diastolic area (RVEDA) and left ventricular end-systolic area (LVEDA) were measured on the apical four-chamber section by two-dimensional ultrasound.
Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
Pulmonary circulatory resistance (PVR)
Time Frame: Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
Increased PVR can lead to deterioration of RV function.Pulse Doppler imaging (PWD) was used to obtain the pulmonary artery flow spectrum from the pulmonic valve on the short axial section of the parasternal great vessels.
Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
stroke volume index(SVI)
Time Frame: Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
SVI is monitored by two-dimension ultrasound
Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
cardiac index (CI)
Time Frame: Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
The amount of blood pumped by the heart in liters per minute divided by the body surface area in square meters
Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
Heart rate(HR)
Time Frame: Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
HR is one of the basic parameters of hemodynamics
Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
Systolic blood pressure(SBP)
Time Frame: Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
SBP is one of the basic parameters of hemodynamics
Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
Mean arterial pressure (MAP)
Time Frame: Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
MAP is one of the basic parameters of hemodynamics
Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
Cardiac output(CO)
Time Frame: Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
The amount of blood expelled from one ventricle per minute
Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
Stroke volume
Time Frame: Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
The amount of blood expelled from one ventricle during a single cardiac beat
Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
Arterial partial pressure of oxygen (PaO2)
Time Frame: Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
PaO2 is one of the key indicators of patients' respiratory status which can be obtained from arterial blood gas analysis.
Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
Arterial partial pressure of carbon dioxide(PaCO2)
Time Frame: Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
PaCO2 is one of the key indicators of pulmonary ventilation which can be obtained from arterial blood gas analysis.
Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
oxygenation index
Time Frame: Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
oxygenation index=PaO2/fraction of inspired oxygen
Before APRV mechanical ventilation and 2, 6, 12, 24, 48, 72 hours after APRV mechanical ventilation
Sequential Organ Failure Assessment score
Time Frame: 2 hours within admission to ICU and 24 hours after inclusion in the study
The higher the Sequential Organ Failure Assessment(SOFA) score(0~24), the higher the disease risk factor and the higher the mortality rate
2 hours within admission to ICU and 24 hours after inclusion in the study
Acute Physiology and Chronic Health Evaluation score
Time Frame: 2 hours within admission to ICU and 24 hours after inclusion in the study
The higher the Acute Physiology and Chronic Health Evaluation(APACHE II) score(0~71), the higher the disease risk factor and the higher the mortality rate. In particular, the accuracy of group patient prediction is high.In particular, the accuracy of group patient prediction is high.
2 hours within admission to ICU and 24 hours after inclusion in the study
Duration of ventilation after randomization
Time Frame: from the day of randomization to the day of extubation or the day of death,assessed up to 90 days
Time to mechanical ventilation in the ICU after randomization or time to mechanical ventilation after randomization until extubation or death
from the day of randomization to the day of extubation or the day of death,assessed up to 90 days
Mortality at 28 days after randomization
Time Frame: 28 days after the beginning of randomization
Mortality at 28 days after randomization
28 days after the beginning of randomization
ICU length of stay
Time Frame: the whole period of stay in ICU from the day of randomization to the day of discharge from ICU or the day of death,assessed up to 90 days
Duration of ICU stay after randomization until surviving transfer out of ICU
the whole period of stay in ICU from the day of randomization to the day of discharge from ICU or the day of death,assessed up to 90 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: xiaojing zou, PhD, Wuhan Union Hospital, China

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2022

Primary Completion (Anticipated)

March 1, 2024

Study Completion (Anticipated)

March 1, 2024

Study Registration Dates

First Submitted

April 5, 2022

First Submitted That Met QC Criteria

June 1, 2022

First Posted (Actual)

June 6, 2022

Study Record Updates

Last Update Posted (Actual)

November 8, 2022

Last Update Submitted That Met QC Criteria

November 2, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • EIT20220109

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on ARDS

3
Subscribe